Vistagen Therapeutics, Inc.
VTGNNASDAQHealthcareBiotechnology
As of Oct 15, 2026 close
- Market cap
- $9.15M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.20$5.14
- Volume (live)
- -
- Avg. volume (3M)
- 21.15M
Vistagen Therapeutics (VTGN) Stock Price & Financial Analysis
Vistagen Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.20 - $0.22 |
|---|---|
| 52-Week High | $5.14 |
| 52-Week Low | $0.20 |
| Open | $0.21 |
| Volume (last close) | 557.97K |
| Average Volume (3M) | 21.15M |
| Revenue (TTM) | 2.50M |
|---|---|
| Net Income (TTM) | -67.62M |
| Free Cash Flow (TTM) | -62.38M |
| EPS (TTM) | −$1.68 |
| Profit Margin | -2702.64% |
| Operating Margin | -2784.33% |
| Return on Equity (ROE) | -276.21% |
| Debt to Equity | 0.03 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 9.15M |
|---|---|
| Shares Outstanding | 42.98M |
| Price to Sales (P/S) | 3.66 |
| Price to Book (P/B) | 0.37 |
| EV/EBITDA | 0.10 |
| 50-Day MA | $0.26 |
|---|---|
| 200-Day MA | $0.48 |
| 1-Year Change | −94.74% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Vistagen Therapeutics at a Glance
As of the Oct 16, 2026 close, Vistagen Therapeutics (VTGN) has a market capitalization of $9.15M. The stock trades at 3.7× sales. Over the trailing twelve months it lost $67.62M on revenue of $2.50M and burned $62.38M of free cash flow. Revenue grew 287.3% year over year.
As of its latest reported balance sheet, it holds $16.99M in cash and securities against $783.00K of debt, a net cash position of $16.21M.
Vistagen Therapeutics does not currently pay a dividend.
The share price is down 94.7% over the past year. At $0.20 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $0.20 to $5.14, below its 200-day moving average of $0.48.
Frequently Asked Questions About Vistagen Therapeutics
What is the current stock price for VTGN?
As of the Oct 16, 2026 close, VTGN stock trades at $0.20. The 52-week range is $0.20–$5.14, with a day range of $0.20–$0.22.
What is the P/E ratio for VTGN?
The P/E ratio (Price-to-Earnings) for VTGN is shown in the Key Statistics section. This valuation metric helps compare Vistagen Therapeutics, Inc. to industry peers.
Does VTGN pay dividends?
Vistagen Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for VTGN?
Analyst ratings and recommendations for VTGN are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of VTGN?
As of the Oct 16, 2026 close, Vistagen Therapeutics's market capitalization is $8.6M, classifying it as a micro-cap company. Vistagen Therapeutics operates in the Healthcare sector within the Biotechnology industry.